The refreshed 2026 Honda Pilot won't turn heads, but it is an ergonomic gem. Just right for long trips with the kiddies.

The compact crossover segment is one of the most popular automotive segments in the United States, and while Japanese ...

Read our Denali D3 Light Pods Review to learn how these LED lights enhance visibility and safety on nighttime rides.

Ford and Honda are doubling down on hybrids for 2026 as EV demand softens and consumer preferences shift toward fuel-efficient, practical vehicles. Honda and Ford are shifting focus from EVs to ...

Stacking up in Grasso’s Garage recently has been a slew of EV SUVs. From the EV9 by KIA and the newly redesigned fleet from Audi, EV’s are everywhere. As someone who is certain that vehicles should be ...

Luke started working as a Freelance Writer for HotCars in 2020. After three years, he moved to a more permanent role with the TopSpeed motorcycle content team as a Journalist. One clear trend is ...

The Honda Accord has long played the supporting role in a segment it once helped define. Despite its strong hybrid option and well-tuned ride, the Honda sedan is consistently outsold by the Toyota ...

Honda is recalling more than 70,000 US vehicles over a loss of brake function, which could increase the risk of a crash or injury, auto safety regulators said Wednesday. The recall includes certain ...

Honda issued its third major recall in the last six weeks this week. Honda issued multiple recalls for Civics, Accord Hybrids, and Acura ILX over safety defects. Issues include loose wheel inserts, ...

Jeff Somers is a freelancer who has been writing about writing, books, personal finance, and home maintenance since 2012. When not writing, Jeff spends his free time fixing up his old house. He has ...

Charles has been in the industry for 19 years now, and has worked with brands such as Autocar India, Overdrive, Motoring World, CarWale, BikeWale and Powerdrift. He has more experience reviewing cars, ...

The FDA has placed a hold on Denali Therapeutics’ plans to launch a phase 1 rare disease trial, citing concerns about immune reactions to the investigational treatment recorded in preclinical mouse ...